TABLE 1.
Association between NSCLC patients’ clinicopathological factors and their dichotomized exosomal LINC00917 expressions (*p < 0.05).
| Clinicopathological factors | Patients with low exosomal LINC00917 | Patients with high exosomal LINC00917 | |
|---|---|---|---|
| Patient # (%) 96 | Patient # (%) 83 | p value | |
| Age (years) | |||
| <65 | 26 (27.08%) | 23 (27.71%) | 0.8971 |
| ≥65 | 70 (72.92%) | 60 (72.29%) | — |
| Sex | |||
| M | 72 (75.00%) | 66 (79.52%) | 0.5899 |
| F | 24 (25.00%) | 17 (20.48%) | — |
| Smoker or not | |||
| None | 33 (34.38%) | 22 (26.51%) | 0.2817 |
| Current | 48 (50.00%) | 41 (49.40%) | — |
| Formal | 15 (15.62%) | 20 (24.09%) | — |
| Tumor Subtypes | |||
| squamous-cell carcinoma | 26 (27.08%) | 20 (24.10%) | — |
| Adenocarcinoma | 43 (44.79%) | 43 (51.81%) | 0.6422 |
| Large-cell carcinoma | 27 (28.12%) | 20 (24.09%) | — |
| Tumor Clinical Stages | |||
| I/II | 78 (81.25%) | 51 (61.45%) | 0.0055* |
| III/IV | 18 (18.75%) | 32 (38.55%) | — |
| Tumor Lymph-node metastasis | |||
| Positive | 65 (67.71%) | 61 (73.49%) | 0.4956 |
| Negative | 31 (32.29%) | 22 (26.51%) | — |